Table 2:

Trend analysis for the coefficient of variation and Gini coefficient of waiting times

Cancer type; first treatmentSlope* (95% CI)
CVGini coefficient
Prostate
Chemotherapy−0.009 (−0.016 to −0.002)−0.004 (−0.008 to −0.001)
Radiotherapy−0.061 (−0.072 to −0.051)−0.018 (−0.021 to −0.016)
Surgery−0.058 (−0.072 to −0.045)−0.006 (−0.009 to −0.003)
Breast
Chemotherapy−0.089 (−0.122 to −0.057)−0.007 (−0.018 to 0.004)
Radiotherapy−0.08 (−0.104 to −0.057)0.008 (0.001 to 0.014)
Surgery−0.347 (−0.407 to −0.287)−0.041 (−0.047 to −0.036)
Lung
Chemotherapy−0.113 (−0.147 to −0.08)−0.012 (−0.016 to −0.007)
Radiotherapy−0.105 (−0.129 to −0.081)−0.012 (−0.016 to −0.008)
Surgery−0.17 (−0.207 to −0.133)−0.021 (−0.025 to −0.018)
Colorectal
Chemotherapy−0.06 (−0.085 to −0.035)−0.014 (−0.018 to −0.01)
Radiotherapy−0.062 (−0.109 to −0.015)−0.024 (−0.03 to −0.018)
Surgery− 0.176 (−0.228 to −0.124)−0.013 (−0.017 to −0.01)
  • Note: CI = confidence interval, CV = coefficient of variation.

  • * The slope term indicates the annual change in the CV and the Gini coefficient of the number of days until first treatment for each cancer–treatment type pair. For example, among patients with colorectal cancer who received chemotherapy as their first treatment, the CV of the time to first treatment decreased by 0.06 per year over the study period.